Detalhe da pesquisa
1.
Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Br J Clin Pharmacol
; 87(2): 494-505, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32495380
2.
Inflammatory processes involved in the alteration of liver function biomarkers in adult hospitalized patients treated with parenteral nutrition.
Front Nutr
; 10: 1034481, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36776600
3.
Effect of Fish Oil Parenteral Emulsion Supplementation on Inflammatory Parameters after Esophagectomy.
Nutrients
; 16(1)2023 Dec 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38201870
4.
Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study.
Front Immunol
; 13: 902837, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35844497
5.
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients.
Rev Esp Enferm Dig
; 108(2): 104-5, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26838495
6.
Clinical, randomized, double blind clinical trial to study the effect of parenteral supplementation with fish oil emulsion in the nutritional support in esophagectomized patients.
Medicine (Baltimore)
; 100(25): e26426, 2021 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34160431
7.
Contribution of infliximab population pharmacokinetic model for dose ptimization in ulcerative colitis patients
Rev. esp. enferm. dig
; 108(2): 104-104, feb. 2016. graf
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-148369